Orexo AB (publ) (STO:ORX)
Sweden
· Delayed Price · Currency is SEK 25.00
+0.30 (1.21%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| US Pharma | 577.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| US Pharma Growth | 1.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| HQ & Pipeline | 61.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| HQ & Pipeline Growth | 16.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digital Mental Health Programs | 100.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Digital Mental Health Programs Growth | -75.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| United States | 579.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 0.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union | 55.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union Growth | 20.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | 4.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | -11.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|